Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

QuantumScape Stock Still High-Risk Against Tough Rivals, High Valuation

By Larry Ramer, InvestorPlace Contributor
With many companies working on advanced EV batteries and QS stock still trading at very high valuations, sell QuantumScape stock.

Robinhood Stock Continues To Disappoint as It Risks Becoming Generic

By Dana Blankenhorn, InvestorPlace Contributor
Robinhood is betting it can build its user base based on its brand name, in a world where any company can handle stock trading through an API.

Nvidia Stock Is Finally Showing Signs of Fatigue After Its Big Rally

By Tim Biggam, InvestorPlace Contributor
The rally in NVDA stock is starting to slow as fundamentals and technicals approach extremes. Time to take a guarded short position.

Stay Clear of Zoom Video Stock Until It Gives Back a Lot More Ground

By Dana Blankenhorn, InvestorPlace Contributor
No one seemed to anticipate growth slowing at Zoom, despite the reopening and fierce competition from Google and Microsoft.

7 Short Squeeze Stocks to Sell Before Reddit Traders Cash Out

By Thomas Niel, InvestorPlace Contributor
Taking a look at recent short squeeze stocks, there are plenty that could see big declines once Reddit traders cash in their chips. To reduce the risk of heavy losses, steer clear of these seven right now.

Let’s Be Realistic About Jumia’s Many Problems

By Stavros Georgiadis, CFA, InvestorPlace Contributor
JMIA stock is a mix of very pricey, too risky, and too speculative. Jumia saw big gains in early 2021, but not for its fundamentals.

Dump Skillz Stock Before a Major Correction Takes Any Profits You Have

By Chris Lau, InvestorPlace Contributor
Investors are selling Skillz because it lost momentum and is in the early phases of proving itself with Aarki and Exit Games.

7 Chinese Tech Stocks To Sell Before Regulators Kill Them

By Ian Bezek, InvestorPlace Contributor
Traders are looking for a bottom in Chinese companies. However, these seven Chinese tech stocks could face even more downside going forward.

Cassava Sciences Stock Will Fall Further on Data Manipulation Allegations

By Faizan Farooque, InvestorPlace Contributor
SAVA stock is still one of the best performers this year, but the recent allegations mean shares will fall further as the story develops.

Even After the Crash, Steer Clear of Workhorse Stock

By Ian Bezek, InvestorPlace Contributor
Workhorse's vehicles have failed to meet customers' needs, and a bigger rival is about to IPO. All this bodes ill for WKHS stock.

Tilray Stock Will Say in Limbo Until the U.S. Legalizes Cannabis

By Joel Baglole, InvestorPlace Contributor
Tilray stock had enjoyed a 62% run up between mid-May and mid-June after it finalized its merger with former rival Aphria. The deal made Tilray the largest Canadian cannabis producer with annual revenues of $1 billion and a 17% share of the North American retail market for the recreational drug. But the shares have since fallen back to their pre-merger level of $13 a share.

DiDi Global Is Driving on ‘Death Road’ With Your Money

By Stavros Georgiadis, CFA, InvestorPlace Contributor
After a tumultuous IPO, you'd think the woes of DIDI stock are behind it. Unfortunately it seems like they're only just beginning.

Even After Its Revenue Beat, Stay Away From Clover Stock

By Thomas Niel, InvestorPlace Contributor
While it beat revenue estimates last quarter, there's still plenty that could keep CLOV stock stuck at single-digit prices.

Clover Health Stock Is Covered in Red Flags

By Larry Ramer, InvestorPlace Contributor
Facing an SEC investigation and generating mounting losses, while recently reporting the departure of its CFO, Clover's issues make CLOV stock a sell.

SOS Limited Has Too Many Red Flags for Investors

By David Moadel, InvestorPlace Contributor
Between the regulatory risks and the lack of readily available company information, it's awfully hard to recommend a position in SOS stock.

Novavax Stock Won’t Have Legs in a Reduced-Covid World

By Larry Ramer, InvestorPlace Contributor
There are signs that the pandemic may end soon, and Novavax has had serious supply issues. As a result, NVAX stock looks too risky.

After Reddit Roiled SCWorx Stock Higher, It’s Not Worth Much Moving Forward

By Alex Sirois, InvestorPlace Contributor
WORX stock had phenomenally high short interest rates causing a lot of speculation, but there's nothing to note now to make SCWorx worth your investment.

Ocugen Stock Will Suffer Its Inevitable Demise Sooner Rather Than Later

By Thomas Niel, InvestorPlace Contributor
It may take time for it to experience its ultimate collapse. But as its still a matter of if rather than when? Avoid the risk of seeing a double-digit percentage decline. Stay away from OCGN stock.

Wait For Pinterest Stock to Hit Bottom Before Buying It

By Joel Baglole, InvestorPlace Contributor
Pinterest might be a solid long-term investment, but the social media company's near-term outlook is too cloudy to justify buying its shares.
Load More Articles